ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DOCS Dr. Martens Plc

71.55
0.65 (0.92%)
Last Updated: 10:19:26
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Dr. Martens Plc DOCS London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.65 0.92% 71.55 10:19:26
Open Price Low Price High Price Close Price Previous Close
70.05 70.00 71.70 70.90
more quote information »
Industry Sector
GENERAL RETAILERS

Dr. Martens DOCS Dividends History

Announcement Date Type Currency Dividend Amount Ex Date Record Date Payment Date
28/11/2024InterimGBP0.008506/03/202507/03/202508/04/2025
30/05/2024FinalGBP0.009929/08/202430/08/202401/10/2024
30/11/2023InterimGBP0.015604/01/202405/01/202402/02/2024
01/06/2023FinalGBP0.042808/06/202309/06/202318/07/2023
24/11/2022InterimGBP0.015605/01/202306/01/202303/02/2023
01/06/2022FinalGBP0.042809/06/202210/06/202219/07/2022
09/12/2021InterimGBP0.012213/01/202214/01/202204/02/2022

Top Dividend Posts

Top Posts
Posted at 10/12/2024 15:58 by velocytongo
I know it’s only anecdotal but London and Paris are doing well. There were some amazing offers on Black Friday (I bot another pair of Crewsons) and my daughter got a 20% discount for trading in an old pair.

The new ranges are all designed with a soft leather and lighter sole and all have a two yr guarantee.

The comfort is critical if Docs want to compete with trainers.
Posted at 26/9/2024 08:53 by blackhorse23
Next year they can not effort to pay any dividend, this year dividends came from bank loans
Posted at 23/9/2024 08:54 by blackhorse23
Dividend paid from bank loan saying in RNS, which is bad
Posted at 21/9/2024 13:16 by mr5k
it's the responsibility of the company secretary to issue the rns (which is also the fd in many companies). the mechanism for the issuance is first for the seller or buyer to notify the exchange and the company when a line has been crossed. if docs have not received the notification from the Permira and any other buyers that is not the company's fault.
Posted at 21/9/2024 12:21 by ih_538656
Dave, I would say SDG as a potential recovery play (much smaller size!) could be interesting - however their H1 outlook (16 October) may be dire.

Having aggressively rolled out physical space makes DOCS a more challenging situation. Their price point with cheaper non branded 'substitutes' available also a headwind.
Posted at 20/9/2024 14:55 by ih_538656
Tom, it's a global brand, although yes synonymous with Britain.

This is way wider than lower UK consumer confidence.

I mentioned at the time of the share buy back this was arguably la la land stuff, gearing up the balance sheet, and it may ultimately end with DOCS needing an equity raise That remains my view fwiw.
But no crystal ball as per.
Posted at 20/9/2024 14:22 by tomboyb
DOCs net debt going in the wrong direction -

And cash depreciating -

Overall results this year will therefore be very second-half weighted, particularly from a profit perspective.

Share price may well be very telling here -
Posted at 17/9/2024 21:41 by velocytongo
The Chinese are wearing knock offs which is why Docs no longer sell there.
Posted at 02/8/2024 14:32 by clocktower
Docs problems may soon extend well beyond the USA before very long. Like the market in general DOCS is on the back foot and heading towards 50p if there is any more bad news impo.

DYOR.
Posted at 16/7/2024 13:52 by mr5k
Burberry's issues are very different from Docs. High-end consumer brands have pushed prices beyond inflation for so long that many buyers have said enough. Also, BRBY was trying to elevate the brand to Dior and Versace levels and that has not worked.

I own a BRBY trench coat that cost me £120 25 years ago (as did many colleagues where I worked). That same coat now costs £1,500. Docs pricing is not out of whack with the price of other branded boots (Blundstones (a little more), Birkenstocks (more expensive) Russell and Bromley (even more expensive) and the price points are accessible.

In terms of Asian exposure, Japan and S Korea are performing well (atm) and they closed their operations in China. BRBY is particularly exposed to the latter in terms of direct sales and London, where the duty-free sales benefit was dumped by the Tories (another Brexit benefit).

Docs problems are in the US where the brand is less well established and the market is not as deep as management anticpated.